QTTBQ32 Bio Inc.
- Market cap
- $257.51M
- as of 2026-10-23
- Latest close
- $8.65
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-01-03
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Morrison Jodie PopeCEO | Oct 6 | Oct 14 | S | 3,221 | $8.32 | Sale −$26,798 | 340,038 | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Oct 6 | Oct 14 | S | 917 | $8.32 | Sale −$7,629 | 126,854 | No | Form 4 |
| Kalowski LeeCFO and President | Oct 6 | Oct 14 | S | 1,301 | $8.32 | Sale −$10,824 | 137,170 | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Aug 25 | Aug 27 | S | 2,798 | $16.56 | Sale −$46,335 | 127,771 | No | Form 4 |
| Morrison Jodie PopeCEO | Aug 25 | Aug 27 | S | 9,845 | $16.56 | Sale −$163,033 | 343,259 | No | Form 4 |
| Kalowski LeeCFO and President | Aug 25 | Aug 27 | S | 3,972 | $16.56 | Sale −$65,776 | 138,471 | No | Form 4 |
| Thistle Mary | Jun 12 | Jul 214/A | A · derivative | 10,826 | $12.64 | $136,841 | 10,826 | No | Form 4/A |
| Grayzel David S. | Jun 12 | Jul 214/A | A · derivative | 10,826 | $12.64 | $136,841 | 10,826 | No | Form 4/A |
| Manke Isaac | Jun 12 | Jul 214/A | A · derivative | 10,826 | $12.64 | $136,841 | 10,826 | No | Form 4/A |
| Xu Diyong | Jun 12 | Jul 214/A | A · derivative | 10,826 | $12.64 | $136,841 | 10,826 | No | Form 4/A |
| Iwicki Mark T | Jun 12 | Jul 214/A | A · derivative | 10,826 | $12.64 | $136,841 | 10,826 | No | Form 4/A |
| Laporte Kathleen | Jun 12 | Jul 214/A | A · derivative | 10,826 | $12.64 | $136,841 | 10,826 | No | Form 4/A |
| Lundberg Sven Ante | Jun 12 | Jul 214/A | A · derivative | 10,826 | $12.64 | $136,841 | 10,826 | No | Form 4/A |
| Tzianabos Arthur | Jun 12 | Jul 214/A | A · derivative | 10,826 | $12.64 | $136,841 | 10,826 | No | Form 4/A |
| Kalowski LeeCFO and President | Jul 16 | Jul 20 | A | 53,250 | $0.00 | $0 | 142,443 | No | Form 4 |
| Morrison Jodie PopeCEO | Jul 16 | Jul 20 | A | 132,000 | $0.00 | $0 | 353,104 | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Jul 16 | Jul 20 | A | 37,500 | $0.00 | $0 | 130,569 | No | Form 4 |
| Manke Isaac | Jun 30 | Jul 2 | M | 53,521 | $2.80 | $149,859 | 53,521 | No | Form 4 |
| Manke Isaac | Jun 30 | Jul 2 | M · derivative | 53,521 | $2.80 | $149,859 | not reported | No | Form 4 |
| OrbiMed Capital GP VII LLC | May 28 | Jun 1 | P | 1,250,000 | $8.00 | Purchase +$10,000,000 | 3,502,987 | No | Form 4 |
| OrbiMed Capital GP VII LLC | May 28 | Jun 1 | P | 625,000 | $8.00 | Purchase +$5,000,000 | 625,000 | No | Form 4 |
| Xu Diyong | May 28 | Jun 1 | P | 1,250,000 | $8.00 | Purchase +$10,000,000 | 3,502,987 | No | Form 4 |
| Xu Diyong | May 28 | Jun 1 | P | 625,000 | $8.00 | Purchase +$5,000,000 | 625,000 | No | Form 4 |
| Kalowski LeeCFO and President | Feb 24 | Mar 20 | A | 53,250 | $0.00 | $0 | 89,193 | No | Form 4 |
| Morrison Jodie PopeCEO | Feb 24 | Mar 20 | A | 132,000 | $0.00 | $0 | 221,104 | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Feb 24 | Mar 20 | A | 37,500 | $0.00 | $0 | 93,069 | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Feb 25 | Feb 27 | S | 2,815 | $4.51 | Sale −$12,696 | 55,569 | No | Form 4 |
| Morrison Jodie PopeCEO | Feb 25 | Feb 27 | S | 9,896 | $4.51 | Sale −$44,631 | 89,104 | No | Form 4 |
| Kalowski LeeCFO and President | Feb 25 | Feb 27 | S | 3,995 | $4.51 | Sale −$18,017 | 35,943 | No | Form 4 |
| Lundberg Sven Ante | Jan 15 | Jan 30 | A · derivative | 20,363 | $2.75 | $55,998 | 20,363 | No | Form 4 |
| Grayzel David S. | Jan 15 | Jan 30 | A · derivative | 16,363 | $2.75 | $44,998 | 16,363 | No | Form 4 |
| Laporte Kathleen | Jan 15 | Jan 30 | A · derivative | 23,272 | $2.75 | $63,998 | 23,272 | No | Form 4 |
| Kalowski LeeCFO and President | Dec 2, 2025 | Dec 4, 2025 | S | 9,072 | $3.46 | Sale −$31,389 | 39,938 | No | Form 4 |
| Morrison Jodie PopeCEO | Dec 2, 2025 | Dec 4, 2025 | S | 22,506 | $3.46 | Sale −$77,871 | 99,000 | No | Form 4 |
| Laporte Kathleen | Oct 23, 2025 | Oct 27, 2025 | A · derivative | 53,521 | $2.80 | $149,859 | 53,521 | No | Form 4 |
| Tzianabos Arthur | Oct 23, 2025 | Oct 27, 2025 | A · derivative | 53,521 | $2.80 | $149,859 | 53,521 | No | Form 4 |
| Grayzel David S. | Oct 23, 2025 | Oct 27, 2025 | A · derivative | 53,521 | $2.80 | $149,859 | 53,521 | No | Form 4 |
| Thistle Mary | Oct 23, 2025 | Oct 27, 2025 | A · derivative | 53,521 | $2.80 | $149,859 | 53,521 | No | Form 4 |
| Xu Diyong | Oct 23, 2025 | Oct 27, 2025 | A · derivative | 53,521 | $2.80 | $149,859 | 53,521 | No | Form 4 |
| Manke Isaac | Oct 23, 2025 | Oct 27, 2025 | A · derivative | 53,521 | $2.80 | $149,859 | 53,521 | No | Form 4 |
| Iwicki Mark T | Oct 23, 2025 | Oct 27, 2025 | A · derivative | 53,521 | $2.80 | $149,859 | 53,521 | No | Form 4 |
| Lundberg Sven Ante | Oct 23, 2025 | Oct 27, 2025 | A · derivative | 53,521 | $2.80 | $149,859 | 53,521 | No | Form 4 |
| Kalowski LeeCFO and President | Aug 26, 2025 | Aug 28, 2025 | S | 4,240 | $1.80 | Sale −$7,632 | 49,010 | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Aug 26, 2025 | Aug 28, 2025 | S | 2,990 | $1.80 | Sale −$5,382 | 58,384 | No | Form 4 |
| Morrison Jodie PopeCEO | Aug 26, 2025 | Aug 28, 2025 | S | 10,494 | $1.80 | Sale −$18,889 | 121,506 | No | Form 4 |
| Tzianabos Arthur | Feb 24, 2025 | Feb 27, 2025 | D · derivative | 25,674 | $7.09 | $182,029 | not reported | No | Form 4 |
| Tzianabos Arthur | Feb 24, 2025 | Feb 27, 2025 | A · derivative | 25,674 | $2.54 | $65,212 | 25,674 | No | Form 4 |
| Tzianabos Arthur | Feb 24, 2025 | Feb 27, 2025 | D · derivative | 12,767 | $16.82 | $214,741 | not reported | No | Form 4 |
| Tzianabos Arthur | Feb 24, 2025 | Feb 27, 2025 | A · derivative | 12,767 | $2.54 | $32,428 | 12,767 | No | Form 4 |
| Laporte Kathleen | Feb 24, 2025 | Feb 27, 2025 | D · derivative | 5,431 | $7.29 | $39,592 | not reported | No | Form 4 |
| Laporte Kathleen | Feb 24, 2025 | Feb 27, 2025 | A · derivative | 5,431 | $2.54 | $13,795 | 5,431 | No | Form 4 |
| Laporte Kathleen | Feb 24, 2025 | Feb 27, 2025 | D · derivative | 1,947 | $7.29 | $14,194 | not reported | No | Form 4 |
| Laporte Kathleen | Feb 24, 2025 | Feb 27, 2025 | A · derivative | 1,947 | $2.54 | $4,945 | 1,947 | No | Form 4 |
| Laporte Kathleen | Feb 24, 2025 | Feb 27, 2025 | D · derivative | 12,767 | $16.82 | $214,741 | not reported | No | Form 4 |
| Laporte Kathleen | Feb 24, 2025 | Feb 27, 2025 | A · derivative | 12,767 | $2.54 | $32,428 | 12,767 | No | Form 4 |
| Kalowski LeeCFO and President | Feb 24, 2025 | Feb 27, 2025 | A | 53,250 | $0.00 | $0 | 53,250 | No | Form 4 |
| Kalowski LeeCFO and President | Feb 24, 2025 | Feb 27, 2025 | D · derivative | 16,901 | $17.08 | $288,669 | not reported | No | Form 4 |
| Kalowski LeeCFO and President | Feb 24, 2025 | Feb 27, 2025 | A · derivative | 16,901 | $2.54 | $42,929 | 16,901 | No | Form 4 |
| Kalowski LeeCFO and President | Feb 24, 2025 | Feb 27, 2025 | D · derivative | 161,323 | $16.82 | $2,713,453 | not reported | No | Form 4 |
| Kalowski LeeCFO and President | Feb 24, 2025 | Feb 27, 2025 | A · derivative | 161,323 | $2.54 | $409,760 | 161,323 | No | Form 4 |
| Manke Isaac | Feb 24, 2025 | Feb 27, 2025 | D · derivative | 12,767 | $16.82 | $214,741 | not reported | No | Form 4 |
| Manke Isaac | Feb 24, 2025 | Feb 27, 2025 | A · derivative | 12,767 | $2.54 | $32,428 | 12,767 | No | Form 4 |
| Manke Isaac | Feb 24, 2025 | Feb 27, 2025 | D · derivative | 2,627 | $18.00 | $47,286 | not reported | No | Form 4 |
| Manke Isaac | Feb 24, 2025 | Feb 27, 2025 | A · derivative | 2,627 | $2.54 | $6,673 | 2,627 | No | Form 4 |
| Manke Isaac | Feb 24, 2025 | Feb 27, 2025 | D · derivative | 19,008 | $3.20 | $60,826 | not reported | No | Form 4 |
| Manke Isaac | Feb 24, 2025 | Feb 27, 2025 | A · derivative | 19,008 | $2.53 | $48,090 | 19,008 | No | Form 4 |
| Manke Isaac | Jan 15, 2025 | Feb 27, 2025 | A · derivative | 19,008 | $3.20 | $60,826 | 19,008 | No | Form 4 |
| Lundberg Sven Ante | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 2,013 | $3.13 | $6,301 | not reported | No | Form 4 |
| Lundberg Sven Ante | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 2,013 | $2.54 | $5,113 | 2,013 | No | Form 4 |
| Lundberg Sven Ante | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 6,238 | $3.13 | $19,525 | not reported | No | Form 4 |
| Lundberg Sven Ante | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 6,238 | $2.54 | $15,845 | 6,238 | No | Form 4 |
| Lundberg Sven Ante | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 2,880 | $7.29 | $20,995 | not reported | No | Form 4 |
| Lundberg Sven Ante | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 2,880 | $2.54 | $7,315 | 2,880 | No | Form 4 |
| Lundberg Sven Ante | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 12,767 | $16.82 | $214,741 | not reported | No | Form 4 |
| Lundberg Sven Ante | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 12,767 | $2.54 | $32,428 | 12,767 | No | Form 4 |
| Lundberg Sven Ante | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 1,316 | $44.40 | $58,430 | not reported | No | Form 4 |
| Lundberg Sven Ante | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 23,140 | $3.20 | $74,048 | not reported | No | Form 4 |
| Lundberg Sven Ante | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 23,140 | $2.54 | $58,776 | 23,140 | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Feb 24, 2025 | Feb 26, 2025 | A | 37,500 | $0.00 | $0 | 61,374 | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 32,891 | $7.29 | $239,775 | not reported | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 32,891 | $2.54 | $83,543 | 32,891 | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 13,305 | $7.29 | $96,993 | not reported | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 13,305 | $2.54 | $33,795 | 13,305 | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 17,506 | $7.50 | $131,295 | not reported | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 17,506 | $2.54 | $44,465 | 17,506 | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 56,413 | $16.82 | $948,867 | not reported | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 56,413 | $2.54 | $143,289 | 56,413 | No | Form 4 |
| Thistle Mary | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 12,767 | $16.82 | $214,741 | not reported | No | Form 4 |
| Thistle Mary | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 12,767 | $2.54 | $32,428 | 12,767 | No | Form 4 |
| Grayzel David S. | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 12,767 | $16.82 | $214,741 | not reported | No | Form 4 |
| Grayzel David S. | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 12,767 | $2.54 | $32,428 | 12,767 | No | Form 4 |
| Grayzel David S. | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 2,569 | $18.00 | $46,242 | not reported | No | Form 4 |
| Grayzel David S. | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 2,569 | $2.54 | $6,525 | 2,569 | No | Form 4 |
| Grayzel David S. | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 18,595 | $3.20 | $59,504 | not reported | No | Form 4 |
| Grayzel David S. | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 18,595 | $2.54 | $47,231 | 18,595 | No | Form 4 |
| Campagna JasonChief Medical Officer | Feb 24, 2025 | Feb 26, 2025 | A | 37,500 | $0.00 | $0 | 37,500 | No | Form 4 |
| Campagna JasonChief Medical Officer | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 87,738 | $7.29 | $639,610 | not reported | No | Form 4 |
| Campagna JasonChief Medical Officer | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 87,738 | $2.54 | $222,855 | 87,738 | No | Form 4 |
| Campagna JasonChief Medical Officer | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 17,951 | $7.29 | $130,863 | not reported | No | Form 4 |
| Campagna JasonChief Medical Officer | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 17,951 | $2.54 | $45,596 | 17,951 | No | Form 4 |
| Campagna JasonChief Medical Officer | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 70,687 | $16.82 | $1,188,955 | not reported | No | Form 4 |
| Campagna JasonChief Medical Officer | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 70,687 | $2.54 | $179,545 | 70,687 | No | Form 4 |
| Iwicki Mark T | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 37,222 | $7.29 | $271,348 | not reported | No | Form 4 |
| Iwicki Mark T | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 37,222 | $2.54 | $94,544 | 37,222 | No | Form 4 |
| Iwicki Mark T | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 7,615 | $7.29 | $55,513 | not reported | No | Form 4 |
| Iwicki Mark T | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 7,615 | $2.54 | $19,342 | 7,615 | No | Form 4 |
| Iwicki Mark T | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 25,534 | $16.82 | $429,482 | not reported | No | Form 4 |
| Iwicki Mark T | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 25,534 | $2.54 | $64,856 | 25,534 | No | Form 4 |
| Xu Diyong | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 12,767 | $16.82 | $214,741 | not reported | No | Form 4 |
| Xu Diyong | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 12,767 | $2.54 | $32,428 | 12,767 | No | Form 4 |
| Morrison Jodie PopeCEO | Feb 24, 2025 | Feb 26, 2025 | A | 132,000 | $0.00 | $0 | 132,000 | No | Form 4 |
| Morrison Jodie PopeCEO | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 152,700 | $7.50 | $1,145,250 | not reported | No | Form 4 |
| Morrison Jodie PopeCEO | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 152,700 | $2.54 | $387,858 | 152,700 | No | Form 4 |
| Morrison Jodie PopeCEO | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 152,700 | $7.50 | $1,145,250 | not reported | No | Form 4 |
| Morrison Jodie PopeCEO | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 152,700 | $2.54 | $387,858 | 152,700 | No | Form 4 |
| Morrison Jodie PopeCEO | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 16,901 | $17.08 | $288,669 | not reported | No | Form 4 |
| Morrison Jodie PopeCEO | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 16,901 | $2.54 | $42,929 | 16,901 | No | Form 4 |
| Morrison Jodie PopeCEO | Feb 24, 2025 | Feb 26, 2025 | D · derivative | 394,445 | $16.82 | $6,634,565 | not reported | No | Form 4 |
| Morrison Jodie PopeCEO | Feb 24, 2025 | Feb 26, 2025 | A · derivative | 394,445 | $2.54 | $1,001,890 | 394,445 | No | Form 4 |
| Lundberg Sven Ante | Jan 15, 2025 | Feb 26, 2025 | A · derivative | 23,140 | $3.20 | $74,048 | 23,140 | No | Form 4 |
| Grayzel David S. | Jan 15, 2025 | Feb 26, 2025 | A · derivative | 18,595 | $3.20 | $59,504 | 18,595 | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Oct 15, 2024 | Oct 16, 2024 | M | 6,000 | $7.29 | $43,740 | 23,874 | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Oct 15, 2024 | Oct 16, 2024 | M · derivative | 6,000 | $7.29 | $43,740 | 32,891 | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Oct 11, 2024 | Oct 16, 2024 | M | 4,574 | $3.12 | $14,271 | 17,874 | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Oct 11, 2024 | Oct 16, 2024 | M · derivative | 213 | $3.12 | $665 | not reported | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Oct 11, 2024 | Oct 16, 2024 | M · derivative | 4,361 | $3.12 | $13,606 | not reported | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Oct 8, 2024 | Oct 10, 2024 | M | 13,300 | $3.12 | $41,496 | 13,300 | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Oct 8, 2024 | Oct 10, 2024 | M · derivative | 13,300 | $3.12 | $41,496 | 213 | No | Form 4 |
| Manke Isaac | Apr 1, 2024 | Sep 30, 2024 | A · derivative | 2,627 | $13.42 | $35,254 | 2,627 | No | Form 4 |
| Lundberg Sven Ante | Sep 25, 2024 | Sep 27, 2024 | A · derivative | 1,316 | $44.40 | $58,430 | 1,316 | No | Form 4 |
| Grayzel David S. | Apr 1, 2024 | Aug 14, 2024 | A · derivative | 2,569 | $13.42 | $34,476 | 2,569 | No | Form 4 |
| Tzianabos Arthur | Mar 25, 2024 | Aug 14, 2024 | M | 1,095 | not reported | not reported | 8,248 | No | Form 4 |
| Tzianabos Arthur | Mar 25, 2024 | Aug 14, 2024 | S | 265 | $24.20 | Sale −$6,413 | 7,983 | No | Form 4 |
| Tzianabos Arthur | Mar 25, 2024 | Aug 14, 2024 | M · derivative | 1,095 | $0.00 | $0 | not reported | No | Form 4 |
| Michaud Charles JrSee Remarks | Mar 25, 2024 | Apr 23, 2024 | S | 75 | $24.20 | Sale −$1,815 | 927 | No | Form 4 |
| Alloway PaulSee Remarks | Mar 25, 2024 | Apr 23, 2024 | S | 268 | $24.21 | Sale −$6,488 | 2,596 | No | Form 4 |
| Michaud Charles JrSee Remarks | Mar 25, 2024 | Mar 27, 2024 | M | 6,448 | not reported | not reported | 18,046 | No | Form 4 |
| Michaud Charles JrSee Remarks | Mar 25, 2024 | Mar 27, 2024 | M · derivative | 1,088 | $0.00 | $0 | not reported | No | Form 4 |
| Michaud Charles JrSee Remarks | Mar 25, 2024 | Mar 27, 2024 | M · derivative | 5,360 | $0.00 | $0 | not reported | No | Form 4 |
| Alloway PaulSee Remarks | Mar 25, 2024 | Mar 27, 2024 | M | 23,530 | not reported | not reported | 51,566 | No | Form 4 |
| Alloway PaulSee Remarks | Mar 25, 2024 | Mar 27, 2024 | M · derivative | 5,440 | $0.00 | $0 | not reported | No | Form 4 |
| Alloway PaulSee Remarks | Mar 25, 2024 | Mar 27, 2024 | M · derivative | 18,090 | $0.00 | $0 | not reported | No | Form 4 |
| Lundberg Sven Ante | Mar 25, 2024 | Mar 27, 2024 | A · derivative | 12,767 | $16.82 | $214,741 | 12,767 | No | Form 4 |
| Thistle Mary | Mar 25, 2024 | Mar 27, 2024 | A · derivative | 12,767 | $16.82 | $214,741 | 12,767 | No | Form 4 |
| Kalowski LeeCFO and President | Mar 25, 2024 | Mar 27, 2024 | A · derivative | 161,323 | $16.82 | $2,713,453 | 161,323 | No | Form 4 |
| Laporte Kathleen | Mar 25, 2024 | Mar 27, 2024 | A · derivative | 12,767 | $16.82 | $214,741 | 12,767 | No | Form 4 |
| Violette Shelia M.Chief Scientific Officer | Mar 25, 2024 | Mar 27, 2024 | A · derivative | 56,413 | $16.82 | $948,867 | 56,413 | No | Form 4 |
| Morrison Jodie PopeCEO | Mar 25, 2024 | Mar 27, 2024 | A · derivative | 394,445 | $16.82 | $6,634,565 | 394,445 | No | Form 4 |
| Campagna JasonChief Medical Officer | Mar 25, 2024 | Mar 27, 2024 | A · derivative | 70,687 | $16.82 | $1,188,955 | 70,687 | No | Form 4 |
| Xu Diyong | Mar 25, 2024 | Mar 27, 2024 | A · derivative | 12,767 | $16.82 | $214,741 | 12,767 | No | Form 4 |
| Grayzel David S. | Mar 25, 2024 | Mar 27, 2024 | A · derivative | 12,767 | $16.82 | $214,741 | 12,767 | No | Form 4 |
| Iwicki Mark T | Mar 25, 2024 | Mar 27, 2024 | A · derivative | 25,534 | $16.82 | $429,482 | 25,534 | No | Form 4 |
| Manke Isaac | Mar 25, 2024 | Mar 27, 2024 | A · derivative | 12,767 | $16.82 | $214,741 | 12,767 | No | Form 4 |
| Tzianabos Arthur | Mar 25, 2024 | Mar 27, 2024 | A · derivative | 12,767 | $16.82 | $214,741 | 12,767 | No | Form 4 |
| Tzianabos Arthur | Jan 9, 2024 | Feb 15, 2024 | S | 13,037 | $0.57 | Sale −$7,431 | 128,778 | Yes | Form 4 |
| Tzianabos Arthur | Jan 1, 2024 | Feb 15, 2024 | M | 14,280 | not reported | not reported | 122,675 | Yes | Form 4 |
| Tzianabos Arthur | Jan 1, 2024 | Feb 15, 2024 | M | 19,140 | not reported | not reported | 141,815 | Yes | Form 4 |
| Tzianabos Arthur | Jan 1, 2024 | Feb 15, 2024 | M · derivative | 14,280 | $0.00 | $0 | not reported | Yes | Form 4 |
| Tzianabos Arthur | Jan 1, 2024 | Feb 15, 2024 | M · derivative | 19,140 | $0.00 | $0 | 19,720 | Yes | Form 4 |
| Michaud Charles JrSee Remarks | Jan 3, 2024 | Jan 5, 2024 | S | 1,708 | $0.57 | Sale −$974 | 11,598 | No | Form 4 |
| Alloway PaulSee Remarks | Jan 3, 2024 | Jan 5, 2024 | S | 7,280 | $0.57 | Sale −$4,150 | 28,036 | No | Form 4 |
| Alloway PaulSee Remarks | Jan 1, 2024 | Jan 3, 2024 | M | 4,420 | not reported | not reported | 21,126 | No | Form 4 |
| Alloway PaulSee Remarks | Jan 1, 2024 | Jan 3, 2024 | M | 5,280 | not reported | not reported | 26,406 | No | Form 4 |
| Alloway PaulSee Remarks | Jan 1, 2024 | Jan 3, 2024 | M | 8,910 | not reported | not reported | 35,316 | No | Form 4 |
| Alloway PaulSee Remarks | Jan 1, 2024 | Jan 3, 2024 | M · derivative | 4,420 | $0.00 | $0 | not reported | No | Form 4 |
| Alloway PaulSee Remarks | Jan 1, 2024 | Jan 3, 2024 | M · derivative | 5,280 | $0.00 | $0 | 5,440 | No | Form 4 |
| Alloway PaulSee Remarks | Jan 1, 2024 | Jan 3, 2024 | M · derivative | 8,910 | $0.00 | $0 | 18,090 | No | Form 4 |
| Michaud Charles JrSee Remarks | Jan 1, 2024 | Jan 3, 2024 | M | 544 | not reported | not reported | 9,610 | No | Form 4 |
| Michaud Charles JrSee Remarks | Jan 1, 2024 | Jan 3, 2024 | M | 1,056 | not reported | not reported | 10,666 | No | Form 4 |
| Michaud Charles JrSee Remarks | Jan 1, 2024 | Jan 3, 2024 | M | 2,640 | not reported | not reported | 13,306 | No | Form 4 |
| Michaud Charles JrSee Remarks | Jan 1, 2024 | Jan 3, 2024 | M · derivative | 544 | $0.00 | $0 | not reported | No | Form 4 |
| Michaud Charles JrSee Remarks | Jan 1, 2024 | Jan 3, 2024 | M · derivative | 1,056 | $0.00 | $0 | 1,088 | No | Form 4 |
| Michaud Charles JrSee Remarks | Jan 1, 2024 | Jan 3, 2024 | M · derivative | 2,640 | $0.00 | $0 | 5,360 | No | Form 4 |